New consent process for use of newborn screening blood samples
This trial tests a new, easier-to-understand consent process for mothers who just gave birth. If you join, you will be asked for permission to use a small leftover blood sample from your baby's newborn screening for research purposes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You speak English, Spanish, or Arabic.
- You have just given birth and are currently in the Mother & Baby Unit at the hospital.
- Your baby was born full-term (at least 37 weeks of pregnancy).
- Your baby is not in the Neonatal Intensive Care Unit (NICU).
- You are not planning to place your baby for adoption, and legal guardianship is known.
- You are willing to take part in a new way of asking for permission to use leftover newborn screening blood samples for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps pregnant people make informed choices about genetic screening tests by providing clear, timely information. Researchers want to learn the best way to explain screening options so you can decide what's right for you and your family.
This pilot study tries a systematic way to look for several rare “lysosomal storage” diseases in newborns using a specialized lab test on routine blood samples. It may help detect these conditions earlier so treatment can start sooner if needed.
This study tests if a digital media tool helps parents decide to join the WHEAT Trial, which studies a treatment for very premature babies. If you are considering the WHEAT Trial for your baby, this study may apply to you.
This study tests whether a digital storytelling program can improve your knowledge and attitudes about newborn screening. If you join, you'll get educational materials on your phone and help researchers see if they are effective.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
This study is testing a new way to screen newborns for certain health conditions by analyzing their DNA from a small blood sample. It aims to see if parents find this type of screening acceptable and helpful.
Hear when a new Implementation Science trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.